Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser

被引:11
作者
Biondo, G. [1 ]
Greco, S. [1 ]
Mavilia, L. [1 ]
Mercuri, S. R. [1 ]
机构
[1] San Raffaele Sci Univ Inst, Unit Dermatol & Cosmetol, Milan, Italy
关键词
RAPAMYCIN;
D O I
10.1111/ced.12327
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Tuberous sclerosis (TS) is a genodermatosis characterized by facial angiofibromas (FAs). These tumours cause aesthetic disfigurement and obstruction of vision, and haemorrhage when traumatized, which can lead to emotional distress and relationship difficulties. We report the case of a 35-year-old patient with extensive TS-associated FAs that were treated with an ultrapulse carbon dioxide laser (UPCDL). UPCDL laser seems to be a easy, useful and convenient tool for the treatment of nodular FAs, which provides good aesthetic results, and a positive response from patients, who report high levels of satisfaction with the results. Minimal recurrence of the tumours occurred during long-term follow-up, and these were successfully treated with UPCDL. It is not yet possible to correct the genetic alterations underlying TS, but UPCDL treatment is a convenient tool to improve the facial appearance of patients with severe FAs.
引用
收藏
页码:738 / 740
页数:3
相关论文
共 6 条
[1]   Tuberous sclerosis [J].
Curatolo, Paolo ;
Bombardieri, Roberta ;
Jozwiak, Sergiusz .
LANCET, 2008, 372 (9639) :657-668
[2]   Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients [J].
Foster, Rachael S. ;
Bint, Lewis J. ;
Halbert, Anne R. .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 (01) :52-56
[3]  
Haemel AK, 2010, ARCH DERMATOL, V146, P715, DOI 10.1001/archdermatol.2010.125
[4]   ANGIOFIBROMAS IN TUBEROUS SCLEROSIS - COMPARISON OF TREATMENT BY CARBON-DIOXIDE AND ARGON-LASER [J].
JANNIGER, CK ;
GOLDBERG, DJ .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1990, 16 (04) :317-320
[5]   Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: A double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin [J].
Mary Kay Koenig ;
Adelaide A. Hebert ;
Joan Roberson ;
Joshua Samuels ;
John Slopis ;
Audrey Woerner ;
Hope Northrup .
Drugs in R&D, 2012, 12 (3) :121-126
[6]   Tuberous sclerosis complex:: Advances in diagnosis, genetics, and management [J].
Schwartz, Robert A. ;
Fernandez, Geover ;
Kotulska, Katarzyna ;
Jozwiak, Sergiusz .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (02) :189-202